Intellia Therapeutics, Inc. (NTLA): Cost of Revenue

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Cost of Revenue is for the year ended 2021-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$0
Year ended 2021-12-31
Period endedCost of RevenueChange YoYSource filing
2021-12-31$0n/a2022-02-24, From 2021-01-01
2020-12-31$0n/a2021-02-26, From 2020-01-01
2019-12-31$0n/a2020-02-27, From 2019-01-01
2018-12-31$0n/a2019-02-27, From 2018-01-01